Is TMHC a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on The deal: $72.50 per share in cash from Berkshire Hathaway, with q1 2026 eps (last full quarter reported) at ~$1.01 (down from ~$2.07). The bear case rests on for former shareholders the main uncertainty is resolved: the merger closed and the consideration was a fixed $72.50 per share in cash, so there is no further price exposure to Taylor Morrison itself. Analysts covering it are spread from $49.00 to $73.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. For former shareholders the main uncertainty is resolved: the merger closed and the consideration was a fixed $72.50 per share in cash, so there is no further price exposure to Taylor Morrison itself. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $49.00, -32.4% from the $72.45 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

The deal: $72.50 per share in cash from Berkshire Hathaway. Under the June 1, 2026 merger agreement, a Berkshire Hathaway subsidiary merged into Taylor Morrison and each share was converted into the right to receive $72.50 in cash. The most optimistic analyst target on TMHC is $73.00, +0.8% from the $72.45 price. That figure is only reachable if this thesis works close to its best case.

For former shareholders the main uncertainty is resolved: the merger closed and the consideration was a fixed $72.50 per share in cash, so there is no further price exposure to Taylor Morrison itself. Practical points remain. Cash proceeds are generally a taxable sale for holders in taxable accounts, with gain or loss measured against each holder's cost basis. Anyone who held shares through a broker should see the cash credited automatically; holders of physical certificates or of shares in unusual registrations may need to follow the paying agent's instructions to collect. Old TMHC tickers in watchlists, screeners or data feeds no longer represent a live security. For anyone looking to replace the exposure, the risks that drove Taylor Morrison's results still apply to other homebuilders: elevated mortgage rates and stretched affordability suppress demand and margins, as Taylor Morrison's Q1 2026 drop to a 20.0% home closings margin showed, and tariffs, inflation, rising cancellations and margin-eroding financing incentives weigh on the whole group. Exposure through Berkshire Hathaway is a very different risk profile, since Taylor Morrison is a small part of a conglomerate dominated by insurance, railroads, utilities and a large equity portfolio. The most pessimistic published target is $49.00, -32.4% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Taylor Morrison Home Corporation is one of the largest homebuilders in the United States, operating across roughly a dozen states in the West, Central, and East regions under the T

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (The deal: $72.50 per share in cash from Berkshire Hathaway) stalling in the reported numbers rather than in the narrative, the risk above (for former shareholders the main uncertainty is resolved: the merger closed and the consideration was a fixed $72.50 per share in cash, so there is no further price exposure to Taylor Morrison itself) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Taylor Morrison is one of the largest US homebuilders, constructing and selling homes across roughly a dozen states under the Taylor Morrison, Darling Homes, and Esplanade brands. It spans entry-level, move-up, luxury, and 55-plus active-adult communities, runs a Yardly build-to-rent business, and offers mortgage, title, and insurance through a Financial Services segment. Since July 24, 2026 it has been a wholly owned subsidiary of Berkshire Hathaway rather than a public company.

Until its acquisition, TMHC was a cyclical stock. Its revenue, margins, and earnings expanded and contracted with mortgage rates, affordability, and the housing cycle rather than growing steadily, which is why it typically traded at a low single-digit to low double-digit earnings multiple. It no longer trades: Berkshire Hathaway acquired the company for $72.50 per share in cash in July 2026.

In Q1 2026, total revenue fell to about $1.39 billion from roughly $1.90 billion a year earlier, home closings dropped to 2,268 units, and net income fell to about $99 million ($1.01 per diluted share) from $213 million. Home closings gross margin narrowed to 20.0% as the company increased discounts and financing incentives. That was the last full quarter Taylor Morrison reported as a public company before Berkshire Hathaway agreed on June 1, 2026 to buy it for $72.50 per share in cash; the deal closed July 24, 2026.